| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,155 | 2,093 | 1,900 | 2,601 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,155 | 2,093 | 1,900 | 2,601 | | | Operating Expenses | | Research Development | 14,384 | 15,806 | 17,749 | 14,774 | | Selling General and Administrative | 3,472 | 4,814 | 4,126 | 4,661 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (15,701) | (18,527) | (19,975) | (16,834) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,046) | (2,348) | (178) | 183 | | Earnings Before Interest And Taxes | (20,747) | (20,875) | (20,153) | (16,651) | | Interest Expense | 65 | 79 | 81 | 131 | | Income Before Tax | (20,812) | (20,954) | (20,234) | (16,782) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (20,812) | (20,954) | (20,234) | (16,782) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (20,812) | (20,954) | (20,234) | (16,782) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($20,812) | ($20,954) | ($20,234) | ($16,782) |
|
0.03% Nasdaq 
Income Statement
